Show Notes
Gopal AB et al., Nat Commun - Structural and functional characterization of two group 2 H3 HA stem antibodies, 2F02 and AG2-G02, shows distinct non-overlapping epitopes, protection in mice, and antigenic changes driven by HA2 position 32 that limit AG2-G02 binding. Key terms: influenza H3N2, hemagglutinin stem, broadly neutralizing antibodies, antigenic evolution, vaccine design.
Study Highlights:
Cryo-EM structures show 2F02 targets the central stem epitope while AG2-G02 targets the lower stem epitope and the two can bind concurrently to an HA trimer. Both antibodies neutralize diverse H3 strains in vitro and provide prophylactic protection in mice, with Fc-mediated effector functions contributing to in vivo efficacy. AG2-G02 binding is lost to recent human H3N2 HAs carrying R32 at HA2, whereas T32 or I32 permit binding. Human plasma binding profiles mirror the historical shift from T32 to I32 to R32, indicating altered population antigenicity of the lower stem over time.
Conclusion:
Natural evolution at HA2 position 32 has changed the antigenicity of the H3N2 HA lower stem, impacting binding of certain group 2 stem antibodies and informing vaccine design strategies
Music:
Enjoy the music based on this article at the end of the episode.
First author:
Gopal AB
Journal:
Nat Commun
DOI:
10.1038/s41467-025-65595-1
Reference:
Gopal AB, Lv H, Ouyang WO, Teo QW, Luo Y, Tang YS, Luo M, Mok CKP, Wu NC. Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity. Nat Commun. 2025;16:10557. https://doi.org/10.1038/s41467-025-65595-1
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
Official website https://basebybase.com
On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/h3n2-stem-antibodies-evolution
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-12-14.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited sections discussing: identification and epitopes of AG2-G02 and 2F02; structural/functional characterization; concurrent binding to an HA trimer; antigenic evolution at HA2 position 32; Fc-mediated protection in vivo; serological/population memory implications; vaccine-design implications.
- transcript topics: Identification and non-overlapping epitopes of AG2-G02 (lower stem) and 2F02 (central stem); Cryo-EM structural analysis and concurrent binding to an HA trimer; Antigenic evolution at HA2 position 32 (T32, I32, R32) and its effect on binding; In vivo Fc-mediated protection and importance of Fc effector functions; Serological analysis across pre-2003 adults, post-2011 adults, and post-2011 infants; Implications for universal influenza vaccine design targeting multiple stem epitopes
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- AG2-G02 targets the lower stem epitope; 2F02 targets the central stem epitope; epitopes are distinct and non-overlapping
- AG2-G02 and 2F02 can bind concurrently to the same HA trimer (non-competitive binding with six Fabs on a single trimer)
- AG2-G02 binding to H3 stem is abrogated by R32HA2; T32HA2 and I32HA2 permit binding
- Population plasma shows immune imprinting: pre-2003 adults bind more to T32HA2; post-2011 infants show stronger binding to R32HA2; post-2011 adults show intermediate patterns
- Fc-mediated effector functions are required for in vivo protection; LALA-PG variants reduce protection
- Two antibodies provide a blueprint for vaccines by targeting both central and lower stem epitopes
QC result: Pass.
